Clinical Trials Directory

Trials / Completed

CompletedNCT02921399

Optimal Initiation of Helicobacter Pylori Eradication After Endoscopic Resection for Gastric Neoplasm

Optimal Initiation of Helicobacter Pylori Eradication After Endoscopic Resection

Status
Completed
Phase
Study type
Observational
Enrollment
149 (actual)
Sponsor
Gangnam Severance Hospital · Academic / Other
Sex
All
Age
20 Years – 90 Years
Healthy volunteers
Not accepted

Summary

After endoscopic resection (ER) of gastric tumors, eradication of Helicobacter pylori (H. pylori) infection is advised to reduce metachronous recurrence. However, few studies have addressed factors influencing H. pylori eradication rates in the aftermath of ER, and none have focused on the optimal timing of therapy to eradicate H. pylori post-ER.Therefore, the investigators will conduct to evaluate whether differences in timing of eradication therapy after ER of gastric tumors.

Detailed description

Uur previous retrospective study unveiled that administering eradication treatment within 2 weeks post-ESD during the active reparative phase of ESD-induced ulcers yielded a markedly higher success rate compared to treatment post-8 weeks during the scarring phase of ESD-induced ulcers.Therefore, we conducted a multicenter, randomized, prospective study to ascertain whether the optimal timing of eradication post-ESD could influence the eradication success rate.

Conditions

Interventions

TypeNameDescription
OTHEReradication timingpatients who underwent ESD for gastric neoplasms were randomized to receive early (3-5 days) or late (8-9 weeks) H. pylori eradication therapy after ESD.

Timeline

Start date
2016-10-10
Primary completion
2021-03-30
Completion
2021-06-30
First posted
2016-10-03
Last updated
2024-04-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02921399. Inclusion in this directory is not an endorsement.